The University of Chicago Header Logo

Connection

Caner Saygin to Prognosis

Back to Details
This is a "connection" page, showing publications Caner Saygin has written about Prognosis.
Caner Saygin
Connection Strength
0.730
Prognosis
  1. Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq. Leukemia. 2021 12; 35(12):3406-3420.
    View in: PubMed
    Score: 0.110
  2. Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia. Leuk Res. 2020 02; 89:106297.
    View in: PubMed
    Score: 0.100
  3. Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes. Blood Adv. 2019 12 23; 3(24):4228-4237.
    View in: PubMed
    Score: 0.099
  4. Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete response. Leuk Lymphoma. 2018 02; 59(2):363-371.
    View in: PubMed
    Score: 0.084
  5. Suicidal ideation among patients with Behçet's syndrome. Clin Exp Rheumatol. 2015 Nov-Dec; 33(6 Suppl 94):S30-5.
    View in: PubMed
    Score: 0.072
  6. Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series. Crit Rev Oncol Hematol. 2013 Nov; 88(2):253-71.
    View in: PubMed
    Score: 0.063
  7. Risk prediction for clonal cytopenia: multicenter real-world evidence. Blood. 2024 Nov 07; 144(19):2033-2044.
    View in: PubMed
    Score: 0.035
  8. Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024 06 18; 14(1):99.
    View in: PubMed
    Score: 0.034
  9. Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer. J Ovarian Res. 2019 Nov 17; 12(1):112.
    View in: PubMed
    Score: 0.025
  10. Predicting Successful Phase Advancement and Regulatory Approval in Multiple Myeloma From Phase I Overall Response Rates. JCO Clin Cancer Inform. 2017 11; 1:1-14.
    View in: PubMed
    Score: 0.021
  11. Genomic determinants of chronic myelomonocytic leukemia. Leukemia. 2017 12; 31(12):2815-2823.
    View in: PubMed
    Score: 0.021
  12. Epithelial-Mesenchymal Transition Markers ß-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study. Pathol Oncol Res. 2015 Sep; 21(4):1209-16.
    View in: PubMed
    Score: 0.018
  13. A 17-year experience with ALL-BFM protocol in acute lymphoblastic leukemia: prognostic predictors and interruptions during protocol. Leuk Res. 2014 Jun; 38(6):699-705.
    View in: PubMed
    Score: 0.017
  14. Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival. J Cancer Res Clin Oncol. 2013 Aug; 139(8):1373-82.
    View in: PubMed
    Score: 0.016
  15. Primary central nervous system lymphoma in immunocompetent individuals: a single center experience. Int J Clin Exp Pathol. 2013; 6(6):1068-75.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.